Skip to main content
. 2021 Jan 29;11:631170. doi: 10.3389/fphar.2020.631170

FIGURE 5.

FIGURE 5

Plot of the surface under the cumulative ranking curves for outcomes. (A) Clinical effectiveness rate; (B) Performance status; (C) leukopenia; (D) hemoglobin reduction; (E) thrombocytopenia; (F) gastrointestinal reactions. Note: The surface under the cumulative ranking curve (SUCRA) was used to estimate the ranking probabilities for different CHIs, which ranged from 0% to 100%. A better treatment is indicated by a higher SUCRA value. NP, vinorelbine and cisplatin; ADI, Aidi injection; AI, Astragalus injection; CSI, Chansu injection; CKSI, Compound kushen injection; DLSI, Delisheng injection; HCSI, Huachansu injection; JOEI, Javanica oil emulsion injection; KAI, Kangai injection; KLTI, Kanglaite injection; SFI, Shenfu injection; SMI, Shenmai injection; SQFZI, Shenqifuzheng injection; SGMI, Shengmai injection; XAPI, Xiaoaiping injection.